Biotech

All Articles

Sanofi pays out $110M upfront for late-stage radioligand therapy

.Sanofi has brought in an overdue access to the radioligand event, paying for 100 thousand europeans...

F 2G rears $100M for 2nd try to receive new antifungal to market

.After F2G's initial effort to acquire a new course of antifungal to market was derailed due to the ...

Moderna targets $1.1 B in R&ampD investing cuts, drops 5 plans surrounded by profitability tensions

.Moderna has pledged to reduce R&ampD investing by $1.1 billion by 2027. The choice to retract the b...

Sanofi's $80M bank on Key dystrophy medicine ends in stage 3 lose big

.Merely 4 months after Sanofi wager $80 million in upfront money on Fulcrum Therapies' losmapimod, t...

Oncternal assets drains 60% surrounded by discharges, trial firings

.Cancer cells provider Oncternal Therapeutics is actually folding all its clinical trials and also l...

Roche is actually carrying out chances that its own injectable obesity possibility can at some point show 25% weight reduction in late-stage test

.Roche is keeping out hopes that its own injectable excessive weight prospect could inevitably demon...

Novo Nordisk hails 'exceptional' weight management lead for dual-acting dental medicine in early test

.Novo Nordisk has actually raised the lid on a phase 1 test of its own oral amylin as well as GLP-1 ...

AbbVie sues BeiGene over blood stream cancer medication classified information

.Just a couple of quick full weeks after gaining an FDA Fast Track tag for its own investigational B...

Lilly delivers one-two punch along with 2nd tranche of good information on regular insulin prospect

.Soon after a beneficial information reduce for Eli Lilly's efsitora alfa, the Indianapolis-based fi...

BridgeBio reduces genetics therapy spending plan as professional data disappoint

.BridgeBio Pharma is actually slashing its genetics therapy spending plan and also drawing back comi...